PhRMA comments to administration on Medicare Part D proposed rule
By Juliet Johnson | January 25, 2019
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) submitted comments in response to the CMS proposed rule, “Modernizing Part D and Medicare Advantage to Lower Drug Prices and...
Read More
Keep the Six Protected Classes, protected
By Juliet Johnson | January 22, 2019
Medicare Part D has been successfully providing seniors with comprehensive drug coverage for more than a decade, and one of the cornerstones of the program has been to ensure the sickest and most...
Read More
Experts agree: the Bipartisan Budget Act changes to Medicare Part D jeopardize the program
By Juliet Johnson | September 24, 2018
The changes made to Part D in the Bipartisan Budget Act (BBA) that passed in February threaten the program’s successful competitive structure. While these changes closed the donut hole a year...
Read More
What if a couple of small fixes could protect seniors in the donut hole and save them money on out-of-pocket costs?
By Juliet Johnson | September 13, 2018
Right now, Congress has the opportunity to make two small fixes that will protect seniors in the Medicare Part D donut hole and save them money on out-of-pocket costs for their medicines. These...
Read More
Medicare Part D cliff ahead
By Juliet Johnson | June 21, 2018
Medicare Part D has been providing seniors with access to prescription drug coverage that meets their needs for more than a decade. Today, more than 42 million people are enrolled in Part D and 90...
Read More
Part D cliff looms for seniors, as program stability could be in jeopardy
By Juliet Johnson | June 18, 2018
For more than a decade, Medicare Part D has successfully provided seniors comprehensive prescription drug coverage that meets their needs, while its market-based structure has kept overall program...
Read More
New “Let’s Talk About Medicare” campaign focuses on solutions to improve affordability and predictability for seniors in Part D
By Juliet Johnson | May 9, 2018
Today, we are launching the “Let’s Talk About Medicare” advertising campaign focused on solutions to improve affordability and predictability for seniors in Medicare Part D. Similar to how the “...
Read More
Burden on patients: Insurance benefit design’s impact on patient access to medicines
By Allyson Funk | June 30, 2016
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS, oncology, cystic fibrosis, mental health and multiple sclerosis. The analysis by Avalere Health presents...
Read More
Burden on patients: Access to medicines in health insurance exchange plans
By Allyson Funk | June 23, 2016
Access to prescription medicines is critical to help patients manage their chronic conditions and maximize quality of life. Unfortunately, even with insurance coverage, many patients still...
Read More
Burden on Patients: 5 Questions on access to rheumatoid arthritis medicines in health exchange plans
By Allyson Funk | December 18, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to...
Read More













